Ameritas Investment Partners’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Ameritas Investment Partners’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-812	Closed	-$5K	–	3290
2021 Q1	$5K	Hold	812	–	–	﹤0.01%	3014
2020 Q4	$4K	Hold	812	–	–	﹤0.01%	3012
2020 Q3	$3K	Hold	812	–	–	﹤0.01%	3054
2020 Q2	$23K	Buy	812 +432	+114%	+$10K	﹤0.01%	2303
2020 Q1	$8K	Hold	380	–	–	﹤0.01%	2659
2019 Q4	$7K	Buy	+380	New	+$5.4K	﹤0.01%	2859

Other funds holding STSA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameritas Investment Partners's STSA Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2021, closing a stake of 812 shares — an estimated $5K sold.

Ameritas Investment Partners first reported a position in STSA in Q4 2019 and held it in 6 quarters. The position peaked at $23K in Q2 2020. 60 funds tracked by Wall St. Rank hold STSA as of Q2 2021.

Ameritas Investment Partners reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 812 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $5K.
Ameritas Investment Partners first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
Ameritas Investment Partners's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $23K in Q2 2020.
60 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.